Fritextsökning
Artiklar per år
Innehållstyper
-
Hansa Medical säljer utvecklingsprojekt
Ett bolag som grundats av life science-profilen Evy Lundgren-Åkerlund köper de fullständiga rättigheterna till Hansa Medicals broskprojekt.
-
Små gottegrisar förklaras biologiskt
Barns sug efter socker är medfött och avtar i takt med att vi slutar växa visar en ny studie.
-
Stopp för djurtestat smink
Idag, den 11 mars, träder EU-förbudet mot att sälja produkter som helt eller delvis har testats på djur. Men förbudet gäller bara vissa typer av produkter.
-
Fortsatt minus för Aerocrine
Omsättningen ökar men resultatet är fortsatt negativt för allergibolaget. Fjolårets kraftiga personalminskning sänker kostnaderna rejält för 2009, och målet är att visa positivt resultat nästa år.
-
Mot börsen med kassan full
Det norska cancerforskningsföretaget Algeta tar in 35 miljoner US-dollar för att fortsätta utvecklingen av sitt mest lovande cancerprojekt.
-
Teori om cancer och kromosomer fel
Längden på kromosomernas ändar, telomererna, har inget med uppkomsten av cancer att göra. Det visar en studie från Umeå universitet.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Pfizer lays a chunky bid on Wyeth
that may lead to lay-offs of some 8,000 persons.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.
-
Fusion between pharma giants?
It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organization TNO Quality of Life.
BREAKING